We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
-4.17%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$68.3B
AUM Growth
-$3.23B
(-4.5%)
Cap. Flow
-$145M
Cap. Flow
% of AUM
-0.21%
Top 10 Holdings %
Top 10 Hldgs %
15.18%
Holding
779
New
72
Increased
344
Reduced
301
Closed
59
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$374M |
| 2 |
FirstEnergy
FE
|
+$348M |
| 3 |
Allstate
ALL
|
+$267M |
| 4 |
Sanofi
SNY
|
+$259M |
| 5 |
JPMorgan Chase
JPM
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$603M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$561M |
| 3 |
Novartis
NVS
|
+$233M |
| 4 |
KLA
KLAC
|
+$233M |
| 5 |
UnitedHealth
UNH
|
+$207M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.86% |
| 2 | Healthcare | 17.72% |
| 3 | Industrials | 14.6% |
| 4 | Technology | 13.23% |
| 5 | Energy | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Robert Half
RHI
$3.61B
| $105M | 0.15% |
1,369,521
-282,740
| -17% | -$22.1M |
|
177
Valvoline
VVV
$4.97B
| $104M | 0.15% |
4,015,530
+22,723
| +0.6% | +$665K |
|
178
nVent Electric
NVT
$24.5B
| $102M | 0.15% |
3,238,564
+230,698
| +8% | +$7.71M |
|
179
Citigroup
C
$222B
| $97.7M | 0.14% |
2,342,360
-128,342
| -5% | -$6.34M |
|
180
NVR
NVR
$17.2B
| $92.9M | 0.14% |
23,311
-1,406
| -6% | -$5.99M |
|
|
ATVI
181
DELISTED
Activision Blizzard
ATVI
| $92.6M | 0.14% |
1,246,476
-1,664,806
| -57% | -$130M |
|
182
Belden
BDC
$4B
| $89.4M | 0.13% |
1,452,931
-51,050
| -3% | -$3.25M |
|
183
Loews
L
$24.3B
| $89.1M | 0.13% |
1,787,356
-108,025
| -6% | -$6.06M |
|
184
ITT
ITT
$17.5B
| $88.6M | 0.13% |
1,356,056
+76,845
| +6% | +$5.6M |
|
185
TransUnion
TRU
$14.8B
| $87.4M | 0.13% |
1,469,197
-489,050
| -25% | -$37.6M |
|
186
Molina Healthcare
MOH
$10.3B
| $86.1M | 0.13% |
260,533
-599,351
| -70% | -$193M |
|
187
Labcorp
LH
$24.3B
| $85.7M | 0.13% |
487,064
+29,447
| +6% | +$6.03M |
|
188
Jabil
JBL
$32.8B
| $84.2M | 0.12% |
1,460,357
-68,960
| -5% | -$4.01M |
|
189
Crown Holdings
CCK
$12.8B
| $81.6M | 0.12% |
1,007,592
-450,781
| -31% | -$42M |
|
|
FRC
190
DELISTED
First Republic Bank
FRC
| $81.3M | 0.12% |
+622,595
| New | +$95.6M |
|
|
CHNG
191
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $80.5M | 0.12% |
2,929,212
-4,158,905
| -59% | -$103M |
|
|
MRO
192
DELISTED
Marathon Oil Corporation
MRO
| $75.6M | 0.11% |
3,342,947
-192,774
| -5% | -$4.57M |
|
193
Domino's
DPZ
$11B
| $73.9M | 0.11% |
238,227
+11,115
| +5% | +$4.22M |
|
194
Insight Enterprises
NSIT
$3.55B
| $73.5M | 0.11% |
865,889
-21,312
| -2% | -$1.9M |
|
195
Frontdoor
FTDR
$5.02B
| $72.5M | 0.11% |
+3,557,141
| New | +$87.2M |
|
196
State Street
STT
$50.9B
| $72.5M | 0.11% |
1,191,075
+70,169
| +6% | +$4.8M |
|
197
ABM Industries
ABM
$2.8B
| $72.2M | 0.11% |
1,827,875
-36,360
| -2% | -$1.59M |
|
198
FedEx
FDX
$74.5B
| $69.8M | 0.1% |
469,795
-318,158
| -40% | -$67.1M |
|
199
Kilroy Realty
KRC
$4.58B
| $69.6M | 0.1% |
1,652,930
-475,979
| -22% | -$24M |
|
200
Analog Devices
ADI
$181B
| $69.4M | 0.1% |
497,845
-29,885
| -6% | -$4.73M |
|
Similar funds
Boston Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Boston Partners held 779 positions worth $68.3B, down 4.5% from $71.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Boston Partners's Q3 2022 filing shows 72 new, 344 increased, 301 reduced and 59 closed positions. Its largest new stake was FirstEnergy: 8,800,892 shares worth $326M. The largest sale was Procter & Gamble, an estimated $603M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
- Boston Partners's largest Q3 2022 buy was FirstEnergy: 8,800,892 shares worth $326M.
- Boston Partners added most to Bristol-Myers Squibb in Q3 2022, an estimated $374M increase.
- Boston Partners's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $561M.
- Boston Partners fully exited Procter & Gamble in Q3 2022, selling an estimated $603M.
- Boston Partners's ten largest holdings make up 15% of its $68.3B portfolio in Q3 2022.
- Boston Partners opened 72 new positions and closed 59 in Q3 2022.
- Boston Partners's portfolio value fell 4.5% quarter-over-quarter to $68.3B.
Based on Boston Partners's 13F filing for Q3 2022, filed 9 Nov 2022.